Cargando…
Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
Resistance to treatment with anticancer drugs is a significant obstacle and a fundamental cause of therapeutic failure in cancer therapy. Functional doxorubicin (DOX) nanoparticles for targeted delivery of the classical cytotoxic anticancer drug DOX to tumor cells, using folate-terminated polyrotaxa...
Autores principales: | Wang, He, Yin, Henghui, Yan, Fengjiao, Sun, Mingna, Du, Lingran, Peng, Wei, Li, Qiuli, Feng, Yinghong, Zhou, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413620/ https://www.ncbi.nlm.nih.gov/pubmed/25605018 |
Ejemplares similares
-
Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018) -
Synthesis of graft polyrotaxane by simultaneous capping of backbone and grafting from rings of pseudo-polyrotaxane
por: Kato, Kazuaki, et al.
Publicado: (2014) -
Polyrotaxane-based supramolecular theranostics
por: Yu, Guocan, et al.
Publicado: (2018) -
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy
por: Pramanik, Dipankar, et al.
Publicado: (2012) -
Supermolecule—Drug Conjugates Based on Acid-Degradable Polyrotaxanes for pH-Dependent Intracellular Release of Doxorubicin
por: Tamura, Atsushi, et al.
Publicado: (2023)